A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
With nine hospitals, eight nursing homes, a geriatric center and the social therapy center Ybbs, the
Vienna Hospital Association (KAV) is one of the largest health facilities in Europe. Around 30,000 employees
take care of the well-being of the people entrusted to them around the clock, 365 days a year.
Vienna, Austria Clinical Trial Location
AKH, Klinik f. Innere Med. I, Onkologie
Währinger Gürtel 18-20, 1090